CLINUVEL PHARMACEUTICALS WKN: A0JEGY ISIN: AU000000CUV3 Forum: Aktien Thema: Hauptdiskussion

🤣

Irgendwas ist hier faul typisch homm aktie inverser tenbagger

Homm*

Weiß jemand, ob der Florian Himmel nochmal was zu Clinuvel gesagt hat ?

Achso ja stimmt hast recht die 70 mille auf dem Konto sind fake weil der Kurs runter ist...

Die bude macht bald dicht der kurs deutet darauf hin

Ja Wie meinen ?

Wie meinen?

Rip analoceuticals

https://www.bioworld.com/articles/499623-clinuvel-announces-new-indications-for-scenesse?v=preview

https://themarketherald.com.au/clinuvel-pharmaceuticals-asxcuv-posts-quarterly-growth-as-scenesse-demand-stays-strong-2020-10-29/

Die Reaktion ist naja aber gut da spielt das Umfeld mit rein und das meiste war ja bekannt

https://cdn-api.markitdigital.com/apiman-gateway/ASX/asx-research/1.0/file/2924-02301275-3A554063?access_token=83ff96335c2d45a094df02a206a39ff4 Und das müsste dan der quartalsbericht sein

In the USA, the distribution of SCENESSE® has progressed ahead of the Company’s planning. Twenty-six Specialty Centers (30 were planned by July 2021) have been trained and accredited to administer SCENESSE® and over 55 national and local private insurers have agreed to reimburse SCENESSE® either under Prior Authorization arrangements, acceptance as a special drug or as part of their formulary listing.

Danke 👍🏻

https://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=02301325 KEY HIGHLIGHTS: SEPTEMBER QUARTER 2020 • Cash receipts of $12,015,000 • Operating expenditures well controlled • Net operating cash flow of $7,881,000 • Further capital invested in Singaporean Research, Development & Innovation Centre • Dividend distribution to shareholders of $1,235,000 • Cash and cash equivalents on hand increased 9% to $72,759,000